Taking people in GermanyNo phase
Testing New Heart Blood Markers for Suspected Heart Attack Diagnosis
Studies new heart blood markers in adults with suspected heart attack.
Key facts
- Who runs it
- Universitätsklinikum Hamburg-Eppendorf
- Where
- Hamburg, GermanySee the site
- Trial code
- Registry title
- Biomarkers in Acute Cardiac Care
- Status
- Recruiting
- People taking part
- 5,000 people, planned
- Started
- Jul 2013
- Expected to end
- Dec 2027
- Type of study
- Observational
- Record updated
- 13 May 2024
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with symptoms that may point to a heart attack. It studies new blood markers for diagnosing acute coronary syndrome.
- Age
- 18 years or older
- Sex
- All sexes can join
- Disease stage
- Symptoms suggestive of acute myocardial infarction (heart attack)
Main reasons for not taking part
- Not enough knowledge of the German language (must be able to understand and write German)
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- Symptoms suggestive of acute myocardial infarction
- Ability to provide written informed consent in accordance with Good epidemiological Practice and local legislation
- Individuals at least 18 years old
Who cannot take part
- Insufficient knowledge of the German language (able to understand and write the German language)
Where in Germany
- Department of Cardiology, University Heart Center HamburgHamburg, GermanyContact: Johannes Neumann, MDTaking people
About the trial
What the trial wants to find out
The primary aim of the study is to investigate new cardiac biomarkers and algorithms to diagnose acute coronary syndrome in patients with suspected acute myocardial infarction.
The group in the trial
- Suspected acute myocardial infarction
Patients with recent onset symptoms suggesting acute myocardial infarction
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Biomarkers in Acute Cardiac Care
- Plain-language title
- Testing New Heart Blood Markers for Suspected Heart Attack DiagnosisGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Publications
- Comparison of the European Society of Cardiology 0/1-Hour and High-Sensitivity Troponin in the Evaluation of Patients With Suspected Acute Coronary Syndrome 0/2-or-0/3-Hour Algorithms for Rapid Myocardial Infarction Diagnosis: A Prospective Multicenter Study.Journal of the American College of Cardiology, 2026
- Record updated
- 13 May 2024